Sanazole as substrate of xanthine oxidase and microsomal NADPH/cytochrome P450 reductase

I. A. Schepetkin, N. V. Cherdyntseva, V. T. Kagiya

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The influence of sanazole and metronidazole on cytochrome C (Cyt c3+) reduction in the enzyme systems xanthine/xanthine oxidase and NADPH-cytochrome P450 reductase was studied. The addition of sanazole but not metronidazole significantly increased the rate of Cyt c3+ reduction in both enzyme systems. The Lineweaver-Burk plot of the rate of Cyt c3+ reduction (in xanthine/xanthine oxidase system) versus sanazole concentration indicates that the apparent Km for sanazole is about 1.5 mM (in hypoxic medium). The results obtained suggest that xanthine oxidase and microsomal NADPH/cytochrome P450 reductase can be enzymes participating in sanazole bioactivation and manifestation of its radiosensitizing and tumoricidal activity. It is concluded that the ability of sanazole to selectively bioactivate in hypoxic tumor tissue and form immunogenic conjugates with tumor protein can be a starting-point for developing nitroazole drugs with immunomodulation anticancer properties.

Original languageEnglish
Pages (from-to)119-127
Number of pages9
JournalPathophysiology
Volume8
Issue number2
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

NADPH-Ferrihemoprotein Reductase
Xanthine Oxidase
Xanthine
Metronidazole
Enzymes
Immunomodulation
Cytochromes
AK 2123
Neoplasms
Pharmaceutical Preparations
Proteins

Keywords

  • Cytochrome P450 reductase
  • Hypoxia-selective agents
  • Sanazole
  • Xanthine oxidase

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Sanazole as substrate of xanthine oxidase and microsomal NADPH/cytochrome P450 reductase. / Schepetkin, I. A.; Cherdyntseva, N. V.; Kagiya, V. T.

In: Pathophysiology, Vol. 8, No. 2, 2001, p. 119-127.

Research output: Contribution to journalArticle

Schepetkin, I. A. ; Cherdyntseva, N. V. ; Kagiya, V. T. / Sanazole as substrate of xanthine oxidase and microsomal NADPH/cytochrome P450 reductase. In: Pathophysiology. 2001 ; Vol. 8, No. 2. pp. 119-127.
@article{95920331285c43dbbc42a680c28a85dc,
title = "Sanazole as substrate of xanthine oxidase and microsomal NADPH/cytochrome P450 reductase",
abstract = "The influence of sanazole and metronidazole on cytochrome C (Cyt c3+) reduction in the enzyme systems xanthine/xanthine oxidase and NADPH-cytochrome P450 reductase was studied. The addition of sanazole but not metronidazole significantly increased the rate of Cyt c3+ reduction in both enzyme systems. The Lineweaver-Burk plot of the rate of Cyt c3+ reduction (in xanthine/xanthine oxidase system) versus sanazole concentration indicates that the apparent Km for sanazole is about 1.5 mM (in hypoxic medium). The results obtained suggest that xanthine oxidase and microsomal NADPH/cytochrome P450 reductase can be enzymes participating in sanazole bioactivation and manifestation of its radiosensitizing and tumoricidal activity. It is concluded that the ability of sanazole to selectively bioactivate in hypoxic tumor tissue and form immunogenic conjugates with tumor protein can be a starting-point for developing nitroazole drugs with immunomodulation anticancer properties.",
keywords = "Cytochrome P450 reductase, Hypoxia-selective agents, Sanazole, Xanthine oxidase",
author = "Schepetkin, {I. A.} and Cherdyntseva, {N. V.} and Kagiya, {V. T.}",
year = "2001",
doi = "10.1016/S0928-4680(01)00073-6",
language = "English",
volume = "8",
pages = "119--127",
journal = "Pathophysiology",
issn = "0928-4680",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Sanazole as substrate of xanthine oxidase and microsomal NADPH/cytochrome P450 reductase

AU - Schepetkin, I. A.

AU - Cherdyntseva, N. V.

AU - Kagiya, V. T.

PY - 2001

Y1 - 2001

N2 - The influence of sanazole and metronidazole on cytochrome C (Cyt c3+) reduction in the enzyme systems xanthine/xanthine oxidase and NADPH-cytochrome P450 reductase was studied. The addition of sanazole but not metronidazole significantly increased the rate of Cyt c3+ reduction in both enzyme systems. The Lineweaver-Burk plot of the rate of Cyt c3+ reduction (in xanthine/xanthine oxidase system) versus sanazole concentration indicates that the apparent Km for sanazole is about 1.5 mM (in hypoxic medium). The results obtained suggest that xanthine oxidase and microsomal NADPH/cytochrome P450 reductase can be enzymes participating in sanazole bioactivation and manifestation of its radiosensitizing and tumoricidal activity. It is concluded that the ability of sanazole to selectively bioactivate in hypoxic tumor tissue and form immunogenic conjugates with tumor protein can be a starting-point for developing nitroazole drugs with immunomodulation anticancer properties.

AB - The influence of sanazole and metronidazole on cytochrome C (Cyt c3+) reduction in the enzyme systems xanthine/xanthine oxidase and NADPH-cytochrome P450 reductase was studied. The addition of sanazole but not metronidazole significantly increased the rate of Cyt c3+ reduction in both enzyme systems. The Lineweaver-Burk plot of the rate of Cyt c3+ reduction (in xanthine/xanthine oxidase system) versus sanazole concentration indicates that the apparent Km for sanazole is about 1.5 mM (in hypoxic medium). The results obtained suggest that xanthine oxidase and microsomal NADPH/cytochrome P450 reductase can be enzymes participating in sanazole bioactivation and manifestation of its radiosensitizing and tumoricidal activity. It is concluded that the ability of sanazole to selectively bioactivate in hypoxic tumor tissue and form immunogenic conjugates with tumor protein can be a starting-point for developing nitroazole drugs with immunomodulation anticancer properties.

KW - Cytochrome P450 reductase

KW - Hypoxia-selective agents

KW - Sanazole

KW - Xanthine oxidase

UR - http://www.scopus.com/inward/record.url?scp=0035193671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035193671&partnerID=8YFLogxK

U2 - 10.1016/S0928-4680(01)00073-6

DO - 10.1016/S0928-4680(01)00073-6

M3 - Article

VL - 8

SP - 119

EP - 127

JO - Pathophysiology

JF - Pathophysiology

SN - 0928-4680

IS - 2

ER -